Corline Biomedical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	459	420	215	320	198	314
Market Cap Growth	44.05%	95.35%	-32.85%	61.60%	-36.85%	29.43%
Enterprise Value	430.99	399.51	197.36	303.2	171.94	272.13
Last Close Price	17.60	16.40	8.78	14.90	9.22	14.60
PE Ratio	-	-	-	-	83.82	-
Forward PE	-	38.92	13.41	3.90	108.00	108.00
PS Ratio	43.00	48.74	12.16	8.91	5.94	18.18
PB Ratio	4.57	4.48	2.47	3.43	2.09	3.40
P/TBV Ratio	-	20.99	14.27	18.49	6.97	8.39
P/FCF Ratio	-	-	-	424.69	-	-
P/OCF Ratio	-	-	-	361.41	-	-
EV/Sales Ratio	40.41	46.35	11.16	8.44	5.16	15.76
EV/EBITDA Ratio	-	-	-	-	72.09	-
EV/EBIT Ratio	-	-	-	-	73.82	-
EV/FCF Ratio	-	-	-	402.12	-	-
Net Debt / Equity Ratio	-	-0.22	-0.20	-0.18	-0.28	-0.45
Net Debt / EBITDA Ratio	2.34	1.40	0.77	10.06	-10.99	6.05
Net Debt / FCF Ratio	1.84	1.16	2.05	-22.56	3.97	8.37
Asset Turnover	0.10	0.09	0.18	0.36	0.33	0.22
Quick Ratio	6.13	4.74	2.59	3.27	4.82	4.71
Current Ratio	6.41	4.98	2.68	3.51	5.00	4.75
Return on Equity (ROE)	-14.57%	-16.29%	-25.74%	-1.93%	2.49%	-9.58%
Return on Assets (ROA)	-13.22%	-15.26%	-23.78%	-1.77%	2.29%	-8.63%
Return on Invested Capital (ROIC)	-18.75%	-19.89%	-30.88%	-2.47%	3.72%	-13.24%
Return on Capital Employed (ROCE)	-13.95%	-16.33%	-25.71%	-1.90%	2.49%	-9.57%
Earnings Yield	-	-	-	-	1.19%	-
FCF Yield	-	-	-	0.24%	-	-
Buyback Yield / Dilution	-10.88%	-13.40%	-1.49%	2.19%	-7.50%	-22.58%
Total Shareholder Return	-10.88%	-13.40%	-1.49%	2.19%	-7.50%	-22.58%